share_log

港股异动 | 东阳光长江药业(01558)涨超7%领涨药品股 近期流感等呼吸道疾病频发

Changes in Hong Kong stocks | Dongguang Changjiang Pharmaceutical (01558) rose more than 7%, leading pharmaceutical stocks to the recent frequent incidence of respiratory diseases such as influenza

Zhitong Finance ·  11/23/2023 15:31

Pharmaceutical stocks continued to rise in the afternoon. As of press release, Dongguang Changjiang Pharmaceutical (01558) rose 6.8% to HK$9.27; Hehuang Pharmaceutical (00013) rose 4.87% to HK$30.15; Sansheng Pharmaceutical (01530) rose 3.77% to HK$7.43; and Shiyao Group (01093) rose 2.63% to HK$7.03.

The Zhitong Finance App learned that pharmaceutical stocks continued to rise in the afternoon. As of press release, Dongguang Changjiang Pharmaceutical (01558) rose 6.8% to HK$9.27; Hehuang Pharmaceutical (00013) rose 4.87% to HK$30.15; Sansheng Pharmaceutical (01530) rose 3.77% to HK$7.43; and Shiyao Group (01093) rose 2.63% to HK$7.03.

According to the news, recently, the Beijing Center for Disease Control and Prevention said that at present, Beijing has entered a season of high incidence of respiratory infectious diseases, showing a trend of common prevalence of various pathogens. Influenza is in the epidemic period, and the number of cases is rising rapidly. The top three reported cases of respiratory infectious diseases in the entire population in Beijing are: influenza, rhinovirus, and respiratory syncytial virus.

The pharmaceutical biology team of Huaan Securities said that the current disadvantages related to pharmaceutical industry policies have come to an end, funds and other institutions have increased month-on-month in pharmaceutical positions. Recently, respiratory diseases such as influenza and pulmonary bronchial coats have been frequent, so it is recommended to focus on related stocks.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment